Top compounds associated with response to ELN


Feature Type Standardized
Nominal ANOVA
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.061 0.08
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.05 0.08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.08
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.22 0.08
mRNA salermide CTRPv2 pan-cancer AAC -0.079 0.08
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.051 0.08
mRNA Bryostatin 1 FIMM pan-cancer AAC -0.25 0.08
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.057 0.08
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.057 0.08
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.061 0.08
Download CSV